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Letters to the Editortransfuse old or young FFP is random
at any given time, the probability of
receiving old or young FFP varied
over the study period. In addition, dur-
ing the 10-year period, operation tech-
niques, transfusion strategies, and
supportive care have also changed.
As a result, the increased survival of
patients receiving young FFP might
not be related to the properties of the
transfused plasma but rather to the im-
provements in operative, supportive,
or nursing strategies, which happen
to temporally coincide with the proba-
bility of receiving young FFP.
We examined time trends in FFP
storage time in The Netherlands by
documenting the storage time of FFP
between 2004 (a new transfusion infor-
mation system was introduced in our
hospital in 2004) and 2009 in the
Leiden University Medical Center.
Table 1 shows that the number of pa-
tients who have received only old FFP
and only young FFP has changed sig-
nificantly during these years. Similar
differencesmay form an alternative ex-
planation for the association between
old FFP and mortality as reported by
van Straten and colleagues. We agree
with the authors that additional studies
are necessary to resolve this issue.
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‘‘NO-TOUCH’’ HARVESTING
AND VASAVASORUM
To the Editor:
Dreifaldt and colleagues1 carried
out an elegant image study to evaluate
the impact of vein graft harvesting
technique on the structure and func-
tion of vasa vasorum. The total area
of vasa vasorum in vein grafts har-
vested with the conventional tech-
nique was significantly reduced in
both the media and the adventitia
compared with vein grafts harvested
with the ‘‘no-touch’’ technique that
preserved an intact vasa vasorum,
whereas the conventional technique
did not.1 These findings corroborate
Dashwood and colleagues’2 hypothe-
sis that vasa vasorum preservation
could represent one of the mecha-
nisms underlying the possible im-
proved patency of saphenous vein
grafts harvested with this technique.2
We would like to share with the au-
thors some thoughts and speculations
based on evidence from the literature.
Three processes are responsible for
vein graft failure: thrombosis, intimal
hyperplasia, and accelerated athero-
sclerosis, which contribute to graft
failure. Studies have shown that
perioperative antiplatelet therapy can
reduce early thrombosis and graft fail-
ure. The ‘‘no-touch’’ technique for har-
vesting grafts may be effective in
preventing disruption to the endothelial
layer and subsequent intimal hyperpla-
sia and graft loss,3 but at least one
apparent paradox has to be clarified
about human saphenous veinvasavaso-
rum. This apparent paradox is based on
the well-known fact that absence of
vasa vasorum is a probable protection
against intramyocardial arteries and
left thoracic artery atherosclerosis.
Recent evidence has shown no clini-
cal disadvantages, andevenadvantages,
of not replacing angiographically pris-
tine grafts at long-term follow-up.Mea-
surements of nitric oxide release of old
saphenous vein grafts, when angio-
graphically pristine, are equal to thatardiovascular Surgery c August 2011of native saphenous veins. These find-
ings support the recent clinical observa-
tions that long-term angiographically
disease-free vein grafts are biologically
privileged.4
The vasa vasorum form a network
of microvasculature to supply oxygen
and nutrients to the outer layers of the
arterial wall. The expansion of the
vasa vasorum to the second order is
associated with neovascularization re-
lated to progression of atherosclerosis.
It was shown that, when arterial grafts
are used in coronary bypass surgery
(eg, internal thoracic artery and right
gastroepiploic artery), the poorly de-
veloped vasa vasorum is related to
better patency.5 However, in saphe-
nous vein graft, the preservation of
vasa vasorum can be associated with
reduction of graft failure.1,2 As al-
readymentioned, is this fact a paradox
or are there functional differences be-
tween arteries and veins? In other
words, the presence of vasa vasorum
in arteries ‘‘facilitates’’ atherosclero-
sis and, on the other hand, its presence
‘‘protects’’ against the same process
of atherosclerosis? That would be an
important point to be investigated.
There are histologic and image
studies showing the human saphenous
structures preservation by using the
‘‘no-touch’’ harvesting. In dealing
with studies on the patency of saphe-
nous vein, Dashwood and colleagues2
provided interesting information about
increasing the human saphenous vein
graft patency in the long-term. How-
ever, the number of patients studied
is small and large trials are still needed
to prove the superiority of grafts har-
vested by the no-touch technique.
The discussion on human saphe-
nous vein harvesting can repeat the in-
ternal thoracic artery skeletonization
saga. In the end, the results of coro-
nary artery bypass grafting with sa-
phenous veins would be similar. It is
necessary to emphasize an important
salutary bias toward the ‘‘no-touch’’
technique, which in principle implies
obsessive care in harvesting the veins.
Letters to the EditorThe end question is, independently
of the harvesting technique, are there
segments of ‘‘biologically privileged’’
vein that randomly will have a good
outcome in the long term?
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ALONE ENOUGH TO IMPROVE
THE SURGICAL OUTCOME?
To the Editor:
We read with interest the report by
Manning and colleagues1 on the series
of 80 patients with congenital tracheal
stenosis undergoing slide tracheo-
plasty (STP).
They conclude that STP, with the use
of cardiopulmonary bypass, is a safe
and reliable technique associated with
low morbidity and mortality. The title
itself underlines the fact that this tech-
nique is also pliable because it could
also be used with extreme anatomic
variants.2 As reported by Manning and
colleagues,1 the age range of patients
undergoing STP can vary from a few
days of life to several years, mainlyThe Journalbecause tracheal stenosis can occur
alone or associated with other anoma-
lies (eg, cardiac, extracardiac, chromo-
somal) that could precipitate the
symptomatology and anticipate the
clinical presentation.When the tracheal
stenosis is isolated, there are different
anatomic variants, such as abnormal
bronchial arborization or functional
single lungs, that can complicate the
preoperative management by requiring
mechanical ventilation (27.5%,1 up to
66%3) and sometimes preoperative ex-
tracorporeal membrane oxygenation to
sustain the hemodynamics.
The use of cardiopulmonary bypass
also is routinely used in our center in
patients with isolated tracheal stenosis
in whom the diameter of the trachea
can be as narrow as 1 or 2 mm and
conventional endotracheal tubes can-
not fit.
The pliability of STP allows the
surgeon to extend the incision into
one of the bronchi when the stenosis
involves segments distal to the ca-
rina.2 However, in the series reported
by Manning and colleagues,1 the in-
volvement of the bronchi in the STP
has not been reported. We believe
that when a stenosis involves the bron-
chi, this must be repaired along with
the trachea.
STP has currently proved its reli-
ability with a better surgical outcome
and lower complication rate when
compared with the other techniques.
We disagree with Manning and col-
leagues’1 statement that the STP itself
is ‘‘largely responsible’’ for their ex-
cellent results.
As reported by our institution, the
management of these complex pa-
tients is multilevel, and intensivists,
surgeons, interventional radiologists,
pneumonologists, and cardiologists
are equally involved. For this reason,
we introduced multidisciplinary man-
agement with a significant improve-
ment of outcome.4
AsManning and colleagues1 report,
42.5% of the patients (34/80) required
at least 1 additional airway interven-
tion, including tracheal dilatation,of Thoracic and Cardiovascular Surgestenting, or reoperation. This indicates
that STP alone does not always work,
because there is still the need for fur-
ther interventions to achieve an ac-
ceptable result.
We believe the management of
patients throughout the follow-up pe-
riod is a key point that must not be
forgotten. A better understanding of
the mid- and long-term effects of tra-
cheal surgery, such as the function of
the airway mucosa or the lung, and
above all on the quality of life, will
be necessary to achieve a thorough
understanding of this very select
population.
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CORONARYARTERY BYPASS
GRAFTING: A META-ANALYSIS
OF PROPENSITY
SCORE–ADJUSTED STUDIES
To the Editor:
We read with great interest the
systematic review and meta-analysis
by Kuss and associates1 of propensity
score analyses, which found on-pump
coronary artery bypass grafting
(CABG) superior to on-pump CABGry c Volume 142, Number 2 475
